
About TVM Capital Life Science
TVM Capital Life Science is a company based in Munchen (Germany). Life Science focused early stage VC firm investing in Europe, Canada, the USA and Asia. It operates on a B2B model.
Company details
Early-stage companies in the life sciences sector are funded by TVM Capital Life Science, with a base in Munich, Germany. Focus is placed on areas such as therapeutics, biotech, medtech, diagnostics, and biopharma. Operations span Europe, Canada, the United States, and Asia. Investments have been directed toward firms including Probiodrug, Evotec, Albireo Pharma, and SpePharm.
- Headquarters Munchen, Germany
- Website tvm-lifescience.com
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tvm Capital Life Science
Complete news archive for TVM Capital Life Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TVM Capital Life Science
TVM Capital Life Science is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Early-stage companies in the life sciences sector are funded by TVM Capital Life Science, with a base in Munich, Germany. Focus is placed on areas such as therapeutics, biotech, medtech, diagnostics, and biopharma. Operations span Europe, Canada, the United States, and Asia. Investments have been directed toward firms including Probiodrug, Evotec, Albireo Pharma, and SpePharm.
